The aim of this review is to draw attention to adverse drug reactions of the drugs that are being used in COVID-19 treatment.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Coronavirus disease 2019 (Covid-19) has been widely spread.
📊
Key Findings & Data:Although many drugs are used in the treatment of COVID-19, there is still no specific treatment with proven reliability and effectiveness and there are many studies to find effective treatment.
💡
Conclusion & Impact:The aim of this review is to draw attention to adverse drug reactions of the drugs that are being used in COVID-19 treatment.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Covid-19 · drug hypersensitivity · adverse effect
Özet
Coronavirus disease 2019 (Covid-19) has been widely spread. Although many drugs are used in the treatment of COVID-19, there is still no specific treatment with proven reliability and effectiveness and there are many studies to find effective treatment. Attention should be taken regarding the properties, interactions and undesired drug reactions of drugs used in the treatment of COVID-19. Side effects and drug hypersensitivity reactions that occur during the use of drugs are undesirable drug reactions. The aim of this review is to draw attention to adverse drug reactions of the drugs that are being used in COVID-19 treatment.
MISIRLIOGLU, E. D., METBULUT, P. (2022). Adverse Drug Reactions During COVID-19 Treatment. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 14 - Sayı: EK SAYI 1, 65–71. https://ajindex.com/articles/627119
Dona I, Salas M, Perez-Sanchez NI, et al. Phenotypes and Natural Evolution of Drug Hypersensitivity. Curr Treat Options Allergy 2019: DOİ 10.1007/s40521-019-0200-1 2-Dona I, Caubet JC, Brockow K, et al. An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity. Clin Transl Allergy. 2018 May 10
Fernandez J, Dona I. Diagnosing and managing patients with drug hypersensitivity. Expert Rev Clin Immunol 2018:14(1):29-41 4-Muraro A, Lemanske R, Castells M, et al. Precision Medicine in Allergic Disease-Food Allergy, Drug Allergy, and Anaphylaxis- PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. Allergy 2017
72(7):1006-1021 5-Demoly P, Adkinson NF, Brockow K, et al. International Consensus on drug allergy. Allergy. 2014 Apr
69(4):420-37 6-Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016(71):149-161 7- Hausmann O. Drug Allergy. Middleton’s Allergy Principles and Practice. 8th edition. Philadelphia. Elsevier 2014:1274-1295 8-https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf 9-Food and Drug Administration (FDA). Coronavirus disease 2019 (COVID-19). 2020.https://www.fda.gov/emergency-preparedness-and response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19. 10-Smith T, Bushek J, Prosser T, COVİD-19 Drug Theraphy. Elsevier 2020. 11- Juurlink D, Safety consideration with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection. CMAJ 2020. 12-https://khgmstokyonetimidb.saglik.gov.tr/TR,64702/hidroksiklorokin-sulfat-200-mg-film-tablet---covid-19-sars-cov2-enfeksiyonu-tedavisinde-kullanilacak-ilaclara-iliskin-bilgilendirme.html 13-Naksuk N, Lazar S, Peeraphatdit TB. Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol. Eur Heart J Acute Cardiovasc Care. 2020 May 6:2048872620922784. 14-Page RL, O’Bryant CL, Cheng D, et al. Drugs that may cause or exacerbate heart failure. Circulation 2016
e32–e69. 15-Lane JCE, Weaver J, Kostka K, et al. Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide- spread use for COVID-19: a multinational, network cohort and self-controlled case series study. medRxiv. 2020. 16-Saleh M, Gabriels